Scpharmaceuticals

Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure

placeLexington, Massachusetts, United States calendar_todayFounded 2013 groups96 employees language scpharmaceuticals.com

Registered entities

Innovation

8 patent families (4 granted) — focus: Human necessities; filing pace accelerating. Cited 1,147 times.

YearFilings
20151
20163
20173
20182
20191
20202
20212
20224
20233
20244
20256
20263

Social engagement

Social engagement: 6.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Orbimed, Sun Pharma.

Investor typeCountShare
Venture capital233%
Private equity233%
Bank & private debt117%
Other / undisclosed117%

Hiring activity

Hires occasionally

2 roles tracked across 1 of the last 12 months

21 Nov 2025 · Regional Sales Director Mid-Atlantic · Philadelphia

10 Nov 2025 · Corporate Account Director Gulf · Atlanta

11 Aug 2025 · Associate Director, Patient Services

Based on job postings tracked across public sources.

Recent activity

3 Oct 2025
Event
HFSA Annual Scientific Meeting 2025
26 Sep 2025
Event
HFSA Devices in Heart Failure Meeting: From Mechanisms to Implementation
23 Sep 2025
Event
HFSA Annual Scientific Meeting 2025
Coming soon